Enterobacter spp.: pathogens poised to flourish at the turn of the century
about
An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree miceBloodstream infections in intensive care unit patients: distribution and antibiotic resistance of bacteriaEnterobacter Meningitis and Challenges in Treatment.Genomic diversity within the Enterobacter cloacae complex.Characterisation and clinical features of Enterobacter cloacae bloodstream infections occurring at a tertiary care university hospital in Switzerland: is cefepime adequate therapy?Molecular epidemiological study of nosocomial Enterobacter aerogenes isolates in a Belgian hospitalInducible beta-lactam resistance in Aeromonas hydrophila: therapeutic challenge for antimicrobial therapyPlasmid-mediated resistance to expanded-spectrum cephalosporins among Enterobacter aerogenes strainsComplete genome sequence of Enterobacter cloacae subsp. cloacae type strain ATCC 13047Extended-spectrum beta-lactamases among Enterobacter isolates obtained in Tel Aviv, Israel.National epidemiologic surveys of Enterobacter aerogenes in Belgian hospitals from 1996 to 1998.Isolation of Pantoea agglomerans in two cases of septic monoarthritis after plant thorn and wood sliver injuries.Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp.Colistin heteroresistance in Enterobacter cloacae is associated with cross-resistance to the host antimicrobial lysozyme.TEM-80, a novel inhibitor-resistant beta-lactamase in a clinical isolate of Enterobacter cloacaeBacteremia due to extended-spectrum-beta-lactamase-producing Enterobacter cloacae: role of carbapenem therapyThe AcrAB-TolC efflux pump contributes to multidrug resistance in the nosocomial pathogen Enterobacter aerogenes.Prevalence and impact of extended-spectrum β-lactamase production on clinical outcomes in cancer patients with Enterobacter species bacteremia.A case of Pantoea endophthalmitis.Prevalence of extended-spectrum beta-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001.Carbapenem resistance in a clinical isolate of Enterobacter aerogenes is associated with decreased expression of OmpF and OmpC porin analogsMicrobial diversity similarities in periodontal pockets and atheromatous plaques of cardiovascular disease patientsDraft Genome Assemblies of Enterobacter aerogenes CDC 6003-71, Enterobacter cloacae CDC 442-68, and Pantoea agglomerans UA 0804-01.Multiple antibiotic-resistant bacteria on fluted pumpkin leaves, a herb of therapeutic value.Emergence in Spain of a multidrug-resistant Enterobacter cloacae clinical isolate producing SFO-1 extended-spectrum beta-lactamaseMultilocus sequence typing (MLST) for characterization of Enterobacter cloacaeExtended-spectrum beta-lactamase enzymes in clinical isolates of Enterobacter species from Lagos, Nigeria.Treatment with a broad-spectrum cephalosporin versus piperacillin-tazobactam and the risk for isolation of broad-spectrum cephalosporin-resistant Enterobacter speciesDissemination of SHV-12 and characterization of new AmpC-type beta-lactamase genes among clinical isolates of enterobacter species in Korea.Enterobacter cloacae pericardial effusion in a frail elderly patient.Multidrug efflux pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus bacterial food pathogensEnterobacter aerogenes and Enterobacter cloacae; versatile bacterial pathogens confronting antibiotic treatment.Characterization of ertapenem-resistant Enterobacter cloacae in a Taiwanese university hospitalInfluence of H7N9 virus infection and associated treatment on human gut microbiota.Involvement of the AcrAB-TolC efflux pump in the resistance, fitness, and virulence of Enterobacter cloacaePantoea species causing early onset neonatal sepsis: a case report[Shoulder tuberculosis masked by concomitant Enterobacter cloacae infection: report of a case].Effect of dosing and dosing frequency on the efficacy of ceftizoxime and the emergence of ceftizoxime resistance during the early development of murine abscesses caused by Bacteroides fragilis and Enterobacter cloacae mixed infectionCefepime Therapy for Monomicrobial Enterobacter cloacae Bacteremia: Unfavorable Outcomes in Patients Infected by Cefepime-Susceptible Dose-Dependent Isolates.Enterobacter sakazakii invasion in human intestinal Caco-2 cells requires the host cell cytoskeleton and is enhanced by disruption of tight junction
P2860
Q24601321-8725C91E-7FCA-479C-9830-114FE9E17A5EQ26795565-4CC9E35B-58E2-4A78-897D-13AEB1AD343DQ30363583-EF11563B-C541-4569-AFFF-226076429EBAQ33361939-07CFA1F6-C437-4DC2-B790-1164966C4CC9Q33601573-BE8BF274-4D1F-4544-82EF-3910F5D9DD4FQ33671868-3E8E410F-8E5A-4782-A112-B0BE79749EC6Q33687738-8240D949-8D01-47FE-9DF3-C9778C7BD82AQ33691113-C0F71D5B-8A7E-41F6-8920-5FD9DF745204Q33825951-A312A35D-E8E4-4B9F-A4A2-F934626A83E2Q33857230-533235EE-ED1F-4EFB-A986-B3E96EB44A50Q33971478-F91000B8-AC65-4AD6-B80E-2328FCAB1EF6Q33975018-8BE1AFE3-DF96-4F47-8703-6FC423C1E174Q33982975-E075EB29-197F-4B0F-8F04-D605693A7236Q34057439-6DE66609-74CD-4B73-B09F-8C5EA8C36951Q34106908-C11DC226-D853-402B-8973-63276DA6D1E8Q34108814-75D2E054-19E4-48C9-92E0-F01A76898D03Q34111927-D7EBA1E3-3200-46DB-9676-4561E4CA1587Q34184631-B6CF5BB9-7271-4947-8C30-92B9AE1C7F45Q34201079-65F1E1F1-2708-4B20-81EE-F7E2765FBB75Q34229879-D5DE26BC-5419-4595-9617-8F0323ED6574Q34252097-2340D979-DD9A-487C-9F2D-4A7619D12EC4Q34351565-7E41AC18-FED5-4B44-81FE-CD9799846BD4Q34398675-CA6DFD59-2DB8-40D1-816C-062D1899F800Q34439588-7D4EA559-2E82-47D4-8F78-AD83B4C24BF3Q34741562-2C45F680-197A-4993-A108-13471FD4CFE3Q34776614-FA9FF86B-1361-4F3B-BBF9-1E589AC3F430Q34991503-4837B708-CA4B-4CFF-8AF9-BE34FF6D449EQ35014507-3EFFC8F1-3BFC-4AA7-A7E7-96AF1F76BE95Q35027042-B0899171-CCD8-4834-BAF6-5A8D8457FEE6Q35109062-57A105E2-288B-4059-8B71-F51F4D87F88CQ35131669-3F08BA15-12A6-4285-A3D5-F9CC579E6A2FQ35617499-3212E601-92D2-4DE4-AFC6-52B8205AB931Q35689071-7EB72EC6-D284-474A-A093-F635ECA1588BQ35816819-C93F4A58-6D30-408B-8BC1-98B16336F058Q35867428-CEEFEC17-1BB1-47D5-B296-065783C1FB5EQ36030371-38E18F27-C25B-41E3-9118-CF4B8637886DQ36031416-4D8D20D1-2D5B-4A3B-ACA4-38059803312BQ36095024-A930CBE1-D56C-4BA2-9F46-7B44DC0A222CQ36290474-24BA9757-E9D2-4DFA-978F-7726AAE447FEQ36421531-73C4EDA3-C746-45B6-847C-7D48CEC196AA
P2860
Enterobacter spp.: pathogens poised to flourish at the turn of the century
description
1997 nî lūn-bûn
@nan
1997 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
name
Enterobacter spp.: pathogens poised to flourish at the turn of the century
@ast
Enterobacter spp.: pathogens poised to flourish at the turn of the century
@en
Enterobacter spp.: pathogens poised to flourish at the turn of the century
@nl
type
label
Enterobacter spp.: pathogens poised to flourish at the turn of the century
@ast
Enterobacter spp.: pathogens poised to flourish at the turn of the century
@en
Enterobacter spp.: pathogens poised to flourish at the turn of the century
@nl
prefLabel
Enterobacter spp.: pathogens poised to flourish at the turn of the century
@ast
Enterobacter spp.: pathogens poised to flourish at the turn of the century
@en
Enterobacter spp.: pathogens poised to flourish at the turn of the century
@nl
P2860
P3181
P1476
Enterobacter spp.: pathogens poised to flourish at the turn of the century
@en
P2093
C C Sanders
W E Sanders
P2860
P304
P3181
P407
P577
1997-04-01T00:00:00Z